Technical Analysis for JNCE - Jounce Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
JNCE closed down 20.0 percent on Friday, January 18, 2019, on 2.06 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
|See historical JNCE trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Fell Below 20 DMA||Bearish||0.00%|
|Jan 18||Fell Below 50 DMA||Bearish||0.00%|
|Jan 18||New Downtrend||Bearish||0.00%|
|Jan 18||Stochastic Sell Signal||Bearish||0.00%|
|Jan 18||Expansion Pivot Sell Setup||Bearish Swing Setup||0.00%|
|Jan 18||Wide Range Bar||Range Expansion||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 18||Down 3 Days in a Row||Weakness||0.00%|
|Jan 17||1,2,3 Pullback Bullish||Bullish Swing Setup||-20.00%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more JNCE news...
|52 Week High||29.25|
|52 Week Low||2.66|
|200-Day Moving Average||8.4114|
|50-Day Moving Average||4.1406|
|20-Day Moving Average||3.9605|
|10-Day Moving Average||4.599|
|Average True Range||0.4029|
|Chandelier Exit (Long, 3 ATRs )||3.7913|
|Chandelier Exit (Short, 3 ATRs )||3.8687|
|Upper Bollinger Band||5.5048|
|Lower Bollinger Band||2.4162|
|Percent B (%b)||0.45|
|MACD Signal Line||0.1276|
|Market Cap||122.19 Million|
|Num Shares||32.2 Million|
|Price-to-Earnings (P/E) Ratio||126.67|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||5.30|
|Resistance 3 (R3)||5.46||5.11||5.05|
|Resistance 2 (R2)||5.11||4.73||5.04||4.97|
|Resistance 1 (R1)||4.46||4.50||4.29||4.30||4.88|
|Support 1 (S1)||3.46||3.73||3.29||3.30||2.72|
|Support 2 (S2)||3.11||3.50||3.04||2.63|
|Support 3 (S3)||2.46||3.11||2.55|
|Support 4 (S4)||2.30|